Literature DB >> 3533117

Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis.

C Bergmann, J Dodt, S Köhler, E Fink, H G Gassen.   

Abstract

A DNA containing the coding sequence for the proteinase inhibitor protein hirudin from the leech Hirudo medicinalis has been obtained by enzymic ligation of chemically synthesized deoxyoligonucleotides. The 226 bp synthetic gene carries signals for the translation initiation and termination. Fragment synthesis was performed by the Khorana ligation method as well as by the fill-in method. Efficiencies of these two methods are compared. The synthetic gene was expressed in E. coli as a fusion protein with beta-galactosidase under the control of the lac-promoter as well as a non-hybrid protein under the control of the lambda PL-promoter. The non-hybrid expression product was shown to have similar biological properties as the authentic protein isolated from the leech.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533117     DOI: 10.1515/bchm3.1986.367.2.731

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  4 in total

Review 1.  Small bite, large impact-saliva and salivary molecules in the medicinal leech, Hirudo medicinalis.

Authors:  Jan-Peter Hildebrandt; Sarah Lemke
Journal:  Naturwissenschaften       Date:  2011-11-09

2.  Production and characterization of hirudin variant-1 by SUMO fusion technology in E. coli.

Authors:  Wuguang Lu; Xueting Cai; Zhenghua Gu; Yuzheng Huang; Binbin Xia; Peng Cao
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

3.  Cell-free synthesis of the hirudin variant 1 of the blood-sucking leech Hirudo medicinalis.

Authors:  Doreen A Wüstenhagen; Phil Lukas; Christian Müller; Simone A Aubele; Jan-Peter Hildebrandt; Stefan Kubick
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

Review 4.  Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review.

Authors:  Chen Junren; Xie Xiaofang; Zhang Huiqiong; Li Gangmin; Yin Yanpeng; Cao Xiaoyu; Gao Yuqing; Li Yanan; Zhang Yue; Peng Fu; Peng Cheng
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.